Long-Term Safety and Efficacy of Tetrabenazine in the Treatment of Chorea Associated with Huntington's Disease

被引：0
|
作者：
Shen, Vivienne [1 ]
Clarence-Smith, Kathleen [2 ]
Hunter, Christine [3 ]
Jankovic, Joseph [3 ]
机构：
[1] Lundbeck Inc, Deerfield, IL USA
[2] KM Pharmaceut Consulting LLC, Washington, DC USA
[3] Baylor Coll Med, Houston, TX 77030 USA
来源：
NEUROLOGY | 2012年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P06034
引用
收藏
页数：3
相关论文
共 50 条
  • [41] TREATMENT OF CHOREA AND ITS EFFICACY IN HUNTINGTON'S DISEASE (HD) PATIENTS
    Cichecki, Filip
    Witkowski, Grzegorz
    Zielonka, Daniel
    Sienkiewicz-Jarosz, Halina
    Stepniak, Iwona
    Ziora-Jakutowicz, Karolina
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 : A72 - A72
  • [42] A study of chorea after tetrabenazine withdrawal in patients with Huntington disease
    Frank, Samuel
    Ondo, William
    Fahn, Stanley
    Hunter, Christine
    Oakes, David
    Plumb, Sandra
    Marshall, Frederick
    Shoulson, Ira
    Eberly, Shirley
    Walker, Francis
    Factor, Stewart
    Hunt, Vicki
    Shinaman, Aileen
    Jankovic, Joseph
    CLINICAL NEUROPHARMACOLOGY, 2008, 31 (03) : 127 - 133
  • [43] SAFETY AND EFFICACY OF LONG-TERM TREATMENT WITH URSODEOXYCHOLIC ACID IN LIVER DISEASE ASSOCIATED WITH CF
    Colombo, C.
    Crosignam, A.
    Zazzeron, L.
    Motta, V
    Battezzati, P.
    PEDIATRIC PULMONOLOGY, 2009, : 412 - 412
  • [44] Comparing Risperidone and Olanzapine to Tetrabenazine for the Management of Chorea in Huntington Disease
    Schultz, Jordan L.
    Kamholz, John A.
    Nopoulos, Peg C.
    Killoran, Annie
    NEUROTHERAPEUTICS, 2018, 15 (04) : 1195 - 1195
  • [45] TetrabenazineFor Chorea Associated with Huntington’s Disease
    Lesley J. Scott
    CNS Drugs, 2011, 25 : 1073 - 1085
  • [46] Monoamine depleter approved for the treatment of chorea associated with Huntington's disease
    不详
    FORMULARY, 2008, 43 (10) : 354 - 354
  • [47] Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease
    Dean, Marissa
    Sung, Victor W.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 313 - 319
  • [48] Testing the Safety and Efficacy of SD-809 for Symptomatic Treatment of Chorea in Huntington Disease
    Testa, C.
    Stamler, D.
    Frank, S.
    NEUROTHERAPEUTICS, 2014, 11 (01) : 222 - 223
  • [49] Sustained Chorea Improvements with Long-Term, Once-Daily Valbenazine in Adults with Huntington's Disease
    Schmolesky, Matthew
    Stimming, Erin Furr
    Claassen, Daniel O.
    Kayson, Elise
    Goldstein, Jody
    Mehanna, Raja
    Hinton, Sean C.
    Klepitskaya, Olga
    Zhang, Hui
    Dunayevich, Eduardo
    Liang, Grace
    Haubenberger, Dietrich
    ANNALS OF NEUROLOGY, 2024, 96 : S224 - S224
  • [50] Sustained Chorea Improvements with Long-Term, Once-Daily Valbenazine in Adults with Huntington's Disease
    Stimming, E. Furr
    Claassen, D.
    Kayson, E.
    Goldstein, J.
    Mehanna, R.
    Hinton, S.
    Klepitskaya, O.
    Zhang, H.
    Dunayevich, E.
    Liang, G.
    Haubenberger, D.
    MOVEMENT DISORDERS, 2024, 39 : S676 - S677
12345